Search by Drug Name or NDC

    NDC 42291-0973-60 Valganciclovir 450 mg/1 Details

    Valganciclovir 450 mg/1

    Valganciclovir is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is VALGANCICLOVIR HYDROCHLORIDE.

    Product Information

    NDC 42291-0973
    Product ID 42291-973_0d0b8a06-8587-2cfe-e063-6294a90af7a0
    Associated GPIs
    GCN Sequence Number 047797
    GCN Sequence Number Description valganciclovir HCl TABLET 450 MG ORAL
    HIC3 W5A
    HIC3 Description ANTIVIRALS, GENERAL
    GCN 13088
    HICL Sequence Number 022033
    HICL Sequence Number Description VALGANCICLOVIR HCL
    Brand/Generic Generic
    Proprietary Name Valganciclovir
    Proprietary Name Suffix n/a
    Non-Proprietary Name Valganciclovir hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 450
    Active Ingredient Units mg/1
    Substance Name VALGANCICLOVIR HYDROCHLORIDE
    Labeler Name AvKARE
    Pharmaceutical Class Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA200790
    Listing Certified Through 2024-12-31

    Package

    NDC 42291-0973-60 (42291097360)

    NDC Package Code 42291-973-60
    Billing NDC 42291097360
    Package 60 TABLET, FILM COATED in 1 BOTTLE (42291-973-60)
    Marketing Start Date 2023-12-21
    NDC Exclude Flag N
    Pricing Information N/A